Published in Blood Weekly, October 30th, 1995
A definite, residual risk of HBV transmission by blood products exists because a window of infectivity for hepatitis B virus (HBV) prevails, indicated Marie-Helene Elghouzzi, National Foundation for Blood Transfusion, Rungis, France, and colleagues ("Transmission of Hepatitis B Virus by HBV Negative Blood Transfusion," Lancet, October 7, 1995;346:964).
Elghouzzi et al. said that their report is the first case in which, using HBV sequencing, the linkage between HBV strains in both the blood donor and the recipient was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.